ArticleCureus2025
Postnatal Cytomegalovirus Infection in a Neonatal Intensive Care Unit: A Retrospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPostnatal cytomegalovirus (pCMV) infection is a relevant cause of morbidity in preterm infants, particularly those born extremely preterm or with very low birth weight. This study aimed to describe the clinical manifestations, management, and outcomes of neonates with pCMV infection admitted to a neonatal intensive care unit (NICU).
methodsWe conducted a retrospective case series of 12 neonates diagnosed with pCMV infection between 2013 and 2024 in a level III NICU. Congenital cytomegalovirus (CMV) infection was excluded by negative urine testing within the first two weeks of life. Clinical, laboratory, and follow-up data were extracted from medical records.
resultsMedian gestational age was 25.0 weeks, and median birth weight was 699.5 grams. All infants were breastfed prior to infection, with the first positive CMV sample detected at a median of 52 days of life. Hematological abnormalities were frequent, including neutropenia in 9/11 (81.8%) and thrombocytopenia in 7/12 (58.3%). Respiratory complications were common, with bronchopulmonary dysplasia in all cases, and intraventricular hemorrhage (IVH) occurred in eight (66.7%). Antiviral therapy was administered in 9/11 (75%) patients, achieving viral clearance in 8/9 (88.9%) treated infants. Overall mortality was 25%.
conclusionpCMV infection in extremely preterm infants is associated with significant morbidity, frequent hematological and respiratory complications, and high mortality. Although antiviral therapy achieved viral clearance in most treated infants, long-term neurodevelopmental impairment was common. Distinguishing sequelae attributable to pCMV from those related to extreme prematurity remains challenging, underscoring the need for prospective studies to better guide management and assess long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.